Patients' access to biological therapy in chronic inflammatory conditions; per capita GDP does not explain the intercountry differences

Ann Rheum Dis. 2016 May;75(5):942-3. doi: 10.1136/annrheumdis-2015-208741. Epub 2016 Feb 17.
No abstract available

Keywords: Ankylosing Spondylitis; DMARDs (biologic); Health services research; Psoriatic Arthritis; Rheumatoid Arthritis.

Publication types

  • Letter

MeSH terms

  • Arthritis / drug therapy
  • Biological Therapy / economics*
  • Chronic Disease
  • Gross Domestic Product / statistics & numerical data*
  • Health Services Accessibility / economics*
  • Humans
  • Inflammation / drug therapy*